肝细胞癌中18F-FDG PET/CT代谢参数与MRI表观扩散系数的预后价值
该回顾性研究纳入52例经病理确诊的肝细胞癌患者,分析肿瘤与正常肝脏SUV比值(TLR)、肿瘤平均ADC值及临床参数与生存的关系。随访期间32例死亡,高TLR(≥2)和低平均ADC与不良结局相关;多因素分析显示TLR≥2、PIVKA-II≥100mAU/mL、肿瘤分期及初始手术治疗是疾病特异性生存的独立相关因素,而平均ADC不是。
要点
- 肿瘤平均SUV与平均ADC呈负相关(r=-0.402,P=0.020)。
- 多因素分析中TLR≥2与疾病特异性生存显著相关(HR 2.46,P=0.044)。
- 平均ADC在多因素分析中不是独立预后因素(HR 0.45,P=0.028为单因素结果)。
核心结论
- 高TLR和低平均ADC与肝细胞癌患者不良结局相关。
- TLR是肝细胞癌患者的独立预后因素,而平均ADC不是。
- 肿瘤平均ADC与平均SUV之间呈负相关(r=-0.402,P=0.020)。
研究设计与样本
- 回顾性分析52例经病理确诊的肝细胞癌患者(年龄57.9±10.7岁,43例男性),均接受MRI和18F-FDG PET/CT检查。
- 获取肿瘤与正常肝脏SUV比值(TLR)、每个肿瘤的平均ADC值及其他临床数据,进行生存分析。
主要发现
- 随访期间32例患者死亡。
- 单因素分析中,疾病特异性生存与以下因素显著相关:高TLR(TLR≥2;HR 3.78;P=0.001)、高平均ADC(平均ADC≥1.250×10 mm/s;HR 0.45;P=0.028)、AFP≥400 ng/mL(HR 3.48;P=0.001)、PIVKA-II≥100mAU/mL(HR 6.39;P=0.011)、肿瘤大小(HR 1.13;P<0.001)、肿瘤数目(HR 2.16;P=0.031)、肿瘤分期(HR 3.08;P<0.001)及初始治疗手术(HR 0.06;P<0.001)。
- 多因素分析显示,疾病特异性生存与以下因素显著相关:TLR≥2(HR 2.46;P=0.044)、PIVKA-II≥100mAU/mL(HR 5.11;P=0.037)、肿瘤分期(HR 3.01;P<0.001)及初始治疗手术(HR 0.04;P<0.001)。
关键数值与推荐
- 单因素分析中,TLR≥2组HR 3.78(P=0.001),平均ADC≥1.250×10 mm/s组HR 0.45(P=0.028),AFP≥400 ng/mL组HR 3.48(P=0.001),PIVKA-II≥100mAU/mL组HR 6.39(P=0.011)。
- 多因素分析中,TLR≥2组HR 2.46(P=0.044),PIVKA-II≥100mAU/mL组HR 5.11(P=0.037),肿瘤分期HR 3.01(P<0.001),初始治疗手术HR 0.04(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to predict the survival of patients with hepatocellular carcinoma (HCC) by examining metabolic PET parameters, apparent diffusion coefficients (ADCs), and clinical parameters. METHODS: We retrospectively reviewed 52 patients with pathologically confirmed HCC (age, 57.9 ± 10.7 years; 43 men) who underwent MRI and F-FDG PET/CT. The tumor-to-normal liver SUV ratio (TLR), the mean ADC of each tumor, and other clinical data were obtained. Survival analysis was performed. RESULTS: Thirty-two patients died during the follow-up period. There was an inverse correlation between the mean SUV and the mean ADC of a tumor (r = -0.402, P = 0.020). Among HCC patients, disease-specific survival was significantly associated with each of the following factors: high TLR (TLR ≥ 2; hazard ratio [HR], 3.78; P = 0.001), high mean ADC (mean ADC ≥ 1.250 × 10 mm/s; HR, 0.45; P = 0.028), AFP ≥ 400 ng/mL (HR, 3.48; P = 0.001), PIVKA-II ≥ 100mAU/mL (HR, 6.39; P = 0.011), tumor size (HR, 1.13; P < 0.001), number of tumors (HR, 2.16; P = 0.031), tumor stage (HR, 3.08; P < 0.001), and surgery for initial treatment (HR, 0.06; P < 0.001). The results of multivariate analysis show that DSS was significantly associated with each of the following factors: TLR ≥ 2 (HR, 2.46; P = 0.044), PIVKA-II ≥ 100mAU/mL (HR, 5.11; P = 0.037), tumor stage (HR, 3.01; P < 0.001), and surgery for initial treatment (HR, 0.04; P < 0.001). CONCLUSIONS: High TLRs and low mean ADCs were associated with poor outcomes. The TLR was an independent prognostic factor in patients with HCC, but the mean ADC was not. A negative correlation was found between the mean ADC and the mean SUV of a tumor.
引用
- Hong CM, Ahn BC, Jang YJ, et al. Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma. Clin Nucl Med. 2017. PMID: 27941378. doi:10.1097/RLU.0000000000001478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。